On The Promise and Paradox of Non-Psychedelic Psychedelics

Psychedelic therapy is emerging as a promising new treatment for depression, anxiety, addiction, and other mental health issues [<a href="https://link.springer.com/article/10.1007/s13311-017-0542-y" rel="noopener ugc nofollow" target="_blank">1</a>]. Many proponents are even envisioning a world in which psychedelic therapy, which is administered once or twice over the course of a month would replace the current status-quo of taking an SSRI daily over the course of months or years. For this to happen psychedelic therapy needs to be broadly accessible — both financially and logistically. Unfortunately that isn’t yet the case. What a typical psychedelic therapy treatment consists of today is often a preliminary introductory session with a therapist on the first day followed by a second day of taking the drug and having the “trip” experience under the supervision of a therapist which is then followed by a third day of working again with a therapist to integrate the insights gained from the experience into one’s life.  <a href="https://awjuliani.medium.com/on-the-promise-and-paradox-of-non-psychedelic-psychedelics-6d5cb088ec7d">Website</a>